Log In
BCIQ
Print this Print this
 

OncoDefender-CRC

  Manage Alerts
Collapse Summary General Information
Company Everist Genomics Inc.
DescriptionColorectal cancer assay based on a 5-gene prognostic signature
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict recurrence risk in patients with stage I/II colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today